Fisher & Paykel Healthcare (NZE:FPH, ASX:FPH) launched the F&P Nova Nasal mask in Australia and New Zealand, according to a Wednesday filing with the bourses in both countries.
The mask is designed to treat obstructive sleep apnea. Fisher & Paykel plans to launch the product in other countries once clearances are received, per the filing.
The company's Kiwi shares were down almost 3% in recent Wednesday trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.